Drug profile

The FDA adverse-event record for Florfenicol,Mometasone Furoate,Terbinafine Hydrochloride

21 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Florfenicol,Mometasone Furoate,Terbinafine Hydrochloride. See the species affected, top reactions, and outcomes below.

21
adverse-event reports
28.6%
death-coded share
Dog
most-reported species
6
Falling - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
21
Total Reports
6
Deaths Reported
28.6%
Death Rate

Active Ingredients

Florfenicol,Mometasone Furoate,Terbinafine Hydrochloride

Administration Routes

Auricular (Otic)UnknownTopical

Species Affected

Dog 19
Cat 2

Most Affected Breeds

Crossbred Canine/dog 3
Retriever - Golden 2
Shih Tzu 2
Pug 2
Poodle - Toy 1
Chihuahua 1
Domestic Longhair 1
Domestic Shorthair 1
Siberian Husky 1
Terrier - Yorkshire 1

Most Reported Reactions

Falling 6
Lethargy (see also Central nervous system depression in Neurological) 5
Vestibular disorder NOS 5
Ocular discharge 4
Eye disorder NOS (for Photophobia see neurological) 4
Death by euthanasia 4
Nystagmus 4
Corneal ulcer 4
Cloudy eye (for Miosis, Mydriasis, Anisocoria, Nystagmus - see Neurological) 4
Circling - neurological disorder (see also Behavioural disorders) 4
Other abnormal test result NOS 4
Not sleeping 3

Outcome Breakdown

Outcome Unknown
8 (38.1%)
Ongoing
6 (28.6%)
Euthanized
4 (19.0%)
Died
2 (9.5%)
Recovered/Normal
1 (4.8%)

Florfenicol,Mometasone Furoate,Terbinafine Hydrochloride Adverse Event Insights

21 reports name Florfenicol,Mometasone Furoate,Terbinafine Hydrochloride; 6 recorded a death outcome (28.6% of reported events, not a population-level mortality rate). Active ingredient: Florfenicol,Mometasone Furoate,Terbinafine Hydrochloride. Administration routes: Auricular (Otic), Unknown, Topical.

By species: Dog (19 reports), Cat (2 reports). By breed: Crossbred Canine/dog (3), Retriever - Golden (2), Shih Tzu (2).

Leading clinical signs: Falling (6), Lethargy (see also Central nervous system depression in Neurological) (5), Vestibular disorder NOS (5), Ocular discharge (4). Outcome, 21 coded reports: Outcome Unknown leads at 38.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.